Keywords:
Pancreas, Oncology, CT, Computer Applications-General, Metabolic disorders
Authors:
E. Kasatkina, V. K. Lyadov, E. A. Mershina, V. Sinitsyn; Moscow/RU
DOI:
10.1594/ecr2012/B-0563
Conclusion
CT is a method of choice for diagnostics of pancreatic cancer and inflammatory diseases of the pancreas.
It is also a useful tool to evaluate sarcopenia in these patients by using L3 skeletal muscle index,
which can be measured using diagnostic CT-scans acquired during the routine care.
Sarcopenia is highly prevalent in patients with pancreatic cancer and chronic pancreatitis (66% in our group of patients) and may be present in patients with any BMI values.
As metabolic disorders are important factor and are to be considered in surgical and combined treatment of pancreatic cancer,
our results show that further research of sarcopenia in this group of patients is needed.
The use of CT for body composition analysis opens up new possibilities in metabolic disorders research.